The Short Answer
Under Asthma, COPD & Respiratory Disease diagnostic criteria (J98.2), workup for Pneumomediastinum integrates FeNO/eosinophil Type-2 inflammation in Pneumomediastinum (J98.2: phenotyping) with evidence-graded therapy tailored to Resting Pulse Oximetry in Pneumomediastinum (J98.2: (SpO2)) response. Under the surface, At the cellular and tissue level in lungs & asthma, Pneumomediastinum (J98.2) involves mucus goblet-cell hyperplasia [Pneumomediastinum J98.2]. progression correlates with shifts in Resting Pulse Oximetry in Pneumomediastinum (J98.2: (SpO2)) (96% – 100% (J98.2)). [1][2].
Hearing or reading "Pneumomediastinum" (coded in medical charts as ICD-10-CM J98.2, and also known as Pneumomediastinum) can feel intimidating when a clinician only has 7 minutes to explain it. In plain kitchen-table terms, Under Asthma, COPD & Respiratory Disease diagnostic criteria (J98.2), workup for Pneumomediastinum integrates FeNO/eosinophil Type-2 inflammation in Pneumomediastinum (J98.2: phenotyping) with evidence-graded therapy tailored to Resting Pulse Oximetry in Pneumomediastinum (J98.2: (SpO2)) response. [1].
Physiologically, At the cellular and tissue level in lungs & asthma, Pneumomediastinum (J98.2) involves mucus goblet-cell hyperplasia [Pneumomediastinum J98.2]. progression correlates with shifts in Resting Pulse Oximetry in Pneumomediastinum (J98.2: (SpO2)) (96% – 100% (J98.2)). [2]. Understanding that root mechanism takes the mystery out of your diagnosis and shows you exactly why targeted daily steps and evidence-based treatments work [2][3].